Freenome, Inc. (FRNM)

Freenome, Inc. in the Healthcare sector is trading at $12.05 with a market capitalization of $1.7B. Wall Street consensus targets $18.00 (5 analysts), implying a +49.4% move over the next 12 months. The stock is currently 31% below its 52-week high of $17.50, remaining 3.9% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 21 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.